Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Cerilliant
Julphar
Cipla
Argus Health
QuintilesIMS
McKinsey
Merck

Generated: September 23, 2018

DrugPatentWatch Database Preview

Lidocaine; tetracaine - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for lidocaine; tetracaine and what is the scope of lidocaine; tetracaine patent protection?

Lidocaine; tetracaine is the generic ingredient in two branded drugs marketed by Taro Pharms and Galen Specialty, and is included in two NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-nine drug master file entries for lidocaine; tetracaine. Four suppliers are listed for this compound.

Summary for lidocaine; tetracaine
US Patents:2
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 29
Suppliers / Packagers: 4
Clinical Trials: 44
DailyMed Link:lidocaine; tetracaine at DailyMed
Pharmacology for lidocaine; tetracaine

US Patents and Regulatory Information for lidocaine; tetracaine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 RX Yes Yes ➤ Sign Up ➤ Sign Up Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for lidocaine; tetracaine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Taro Pharms PLIAGLIS lidocaine; tetracaine CREAM;TOPICAL 021717-001 Jun 29, 2006 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Galen Specialty SYNERA lidocaine; tetracaine PATCH;TOPICAL 021623-001 Jun 23, 2005 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for lidocaine; tetracaine

Country Document Number Estimated Expiration
European Patent Office 1702597 ➤ Sign Up
Canada 2375655 ➤ Sign Up
Japan 2007217431 ➤ Sign Up
European Patent Office 1244401 ➤ Sign Up
World Intellectual Property Organization (WIPO) 0103625 ➤ Sign Up
Germany 60032021 ➤ Sign Up
Australia 7719800 ➤ Sign Up
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Fuji
Cerilliant
Julphar
Cipla
Argus Health
QuintilesIMS
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.